ALT stock forecast
Our latest prediction for Altimmune, Inc.'s stock price was made on the June 15, 2020 when the stock price was at 7.60$.
In the short term (2weeks), ALT's stock price should outperform the market by 0.19%. During that period the price should oscillate between -11.33% and +15.32%.
In the medium term (3months), ALT's stock price should underperform the market by -5.70%. During that period the price should oscillate between -39.56% and +32.00%.Get email alerts
Create a solid portfolio with ALT
About Altimmune, Inc.
Altimmune, Inc. is a clinical stage immunotherapeutic biotechnology company. It focuses on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company's portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. Altimmune was founded in 1997 and is headquartered in Gaithersburg, MD.
At the moment the company generates 5M USD in revenues.
On its last earning announcement, the company reported a loss of -1.59$ per share.
The book value per share is 24.98$
Three months stock forecastJune 15, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|